Boehringer Ingelheim Collaboration to Develop Lung Cancer Therapy

… of HM61713, a therapy for lung cancer. Boehringer Ingelheim and Hanmi Pharmaceutical … treatment of EGFR mutation positive lung cancer. Under the terms of the … of providing a wide-range of lung cancer treatment options as we better … EGFR agent bolsters our existing lung cancer portfolio and reiterates our commitment …